EUVIMEDEUVIMED entdecken
Crossref

Engineered Biomimetic Nanovesicles Synergistically Remodel Folate-Nucleotide and γ-Aminobutyric Acid Metabolism to Overcome Sunitinib-Resistant Renal Cell Carcinoma

Minchao Lv iD, Bin Liu, Yi Duan, Jiangtao Lin, Li Dai, Yuanyuan Li, Jian Yu, Jinghan Liao, Jiali Zhang iD, Yourong Duan iD

ACS Nano · 08.10.2024 · 18 (40) · 27487-27502

DOI: 10.1021/acsnano.4c08055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 27.09.2024. Verfasst von Minchao Lv und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 22…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Drug Resistance, Neoplasm, Kidney Neoplasms, Folic Acid. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality, Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellDrug Resistance, NeoplasmKidney NeoplasmsFolic AcidSunitinibgamma-Aminobutyric AcidManganese CompoundsHumansAnimalsMiceNanoparticlesNucleotidesAntineoplastic AgentsBiomimetic MaterialsCell Line, TumorTumor MicroenvironmentCell ProliferationEpithelial-Mesenchymal TransitionAminohydrolasesMethylenetetrahydrofolate Dehydrogenase (NADP)OxidesMultifunctional Enzymes

Stichwörter der Autor:innen

cancer stem cellscellular metabolic remodelingdrug-resistant clear cell renal cell carcinomaengineered biomimetic nanovesiclesimmune-suppressive tumor microenvironment

Substanzen

Folic AcidSunitinibgamma-Aminobutyric AcidManganese CompoundsNucleotidesAntineoplastic Agentsmanganese dioxideMTHFD2 protein, humanAminohydrolasesMethylenetetrahydrofolate Dehydrogenase (NADP)

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 2200/25 Xietu Rd, Shanghai 200032, China.
  • Department of Otolaryngology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 1678 Dongfang Rd, Shanghai 200127, China.

ORCID-Profile: Minchao Lv, Jiali Zhang, Yourong Duan

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • Innovative Research Team of High-level Local University in Shanghai
  • National Natural Science Foundation of China

Zitieren

APA

Lv, M., Liu, B., Duan, Y., Lin, J., Dai, L., Li, Y., Yu, J., Liao, J., Zhang, J., & Duan, Y. (2024). Engineered Biomimetic Nanovesicles Synergistically Remodel Folate-Nucleotide and γ-Aminobutyric Acid Metabolism to Overcome Sunitinib-Resistant Renal Cell Carcinoma. ACS Nano, 18(40), 27487-27502. https://doi.org/10.1021/acsnano.4c08055

Vancouver

Lv M, Liu B, Duan Y, Lin J, Dai L, Li Y, et al. Engineered Biomimetic Nanovesicles Synergistically Remodel Folate-Nucleotide and γ-Aminobutyric Acid Metabolism to Overcome Sunitinib-Resistant Renal Cell Carcinoma. ACS Nano. 2024;18(40):27487-27502. doi:10.1021/acsnano.4c08055

BibTeX
@article{Lv2024,
  author = {Lv, Minchao and Liu, Bin and Duan, Yi and Lin, Jiangtao and Dai, Li and Li, Yuanyuan and Yu, Jian and Liao, Jinghan and Zhang, Jiali and Duan, Yourong},
  title = {Engineered Biomimetic Nanovesicles Synergistically Remodel Folate-Nucleotide and γ-Aminobutyric Acid Metabolism to Overcome Sunitinib-Resistant Renal Cell Carcinoma},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {40},
  pages = {27487--27502},
  doi = {10.1021/acsnano.4c08055}
}
Kostenlos starten →